BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 15651039)

  • 21. Viral vector approaches to modify gene expression in the brain.
    Papale A; Cerovic M; Brambilla R
    J Neurosci Methods; 2009 Dec; 185(1):1-14. PubMed ID: 19699233
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A review of gene therapy for the treatment of central nervous system tumors.
    Qureshi NH; Chiocca EA
    Crit Rev Oncog; 1999; 10(4):261-74. PubMed ID: 10654926
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Viruses as gene delivery vectors: application to gene function, target validation, and assay development.
    Lotze MT; Kost TA
    Cancer Gene Ther; 2002 Aug; 9(8):692-9. PubMed ID: 12136431
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Prospects for gene treatment in paediatric neurology].
    Bosch A
    Rev Neurol; 2002 Jul 16-31; 35(2):158-62. PubMed ID: 12221630
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mouse models of human neurodegenerative disorders: requirements for medication development.
    Bloom FE; Reilly JF; Redwine JM; Wu CC; Young WG; Morrison JH
    Arch Neurol; 2005 Feb; 62(2):185-7. PubMed ID: 15710845
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Beyond small molecule drugs for heart failure: prospects for gene therapy.
    Chien KR
    Novartis Found Symp; 2006; 274():244-56; discussion 256-9, 272-6. PubMed ID: 17019816
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Technology insight: therapeutic RNA interference--how far from the neurology clinic?
    Gonzalez-Alegre P; Paulson HL
    Nat Clin Pract Neurol; 2007 Jul; 3(7):394-404. PubMed ID: 17611488
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Library selection and directed evolution approaches to engineering targeted viral vectors.
    Jang JH; Lim KI; Schaffer DV
    Biotechnol Bioeng; 2007 Oct; 98(3):515-24. PubMed ID: 17614321
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gene transfer therapy for neurodegenerative disorders.
    Feigin A; Eidelberg D
    Mov Disord; 2007 Jul; 22(9):1223-8; quiz 1369. PubMed ID: 17393533
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Gene therapy and molecular therapeutic for head and neck cancer].
    Tanaka H
    Gan To Kagaku Ryoho; 2005 Dec; 32(13):2046-51. PubMed ID: 16352927
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-viral and viral vectors for gene therapy.
    Boulaiz H; Marchal JA; Prados J; Melguizo C; Aránega A
    Cell Mol Biol (Noisy-le-grand); 2005 Sep; 51(1):3-22. PubMed ID: 16171561
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety of viral vectors for neurological gene therapies.
    Maguire-Zeiss KA; Federoff HJ
    Curr Opin Mol Ther; 2004 Oct; 6(5):473-81. PubMed ID: 15537048
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gene therapy for lysosomal storage diseases.
    Sands MS; Davidson BL
    Mol Ther; 2006 May; 13(5):839-49. PubMed ID: 16545619
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Therapeutic RNA interference for neurodegenerative diseases].
    González-Alegre P
    Rev Neurol; 2008 Dec 16-31; 47(12):641-7. PubMed ID: 19085881
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Simian immunodeficiency virus vector pseudotypes differ in transduction efficiency and target cell specificity in brain.
    Liehl B; Hlavaty J; Moldzio R; Tonar Z; Unger H; Salmons B; Günzburg WH; Renner M
    Gene Ther; 2007 Sep; 14(18):1330-43. PubMed ID: 17611586
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Engineering chromosomes for delivery of therapeutic genes.
    Irvine DV; Shaw ML; Choo KH; Saffery R
    Trends Biotechnol; 2005 Dec; 23(12):575-83. PubMed ID: 16242803
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The future of antihypertensive treatment.
    Israili ZH; Hernández-Hernández R; Valasco M
    Am J Ther; 2007; 14(2):121-34. PubMed ID: 17414579
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic dissection of neurodegeneration and CNS inflammation.
    Olsson T; Piehl F; Swanberg M; Lidman O
    J Neurol Sci; 2005 Jun; 233(1-2):99-108. PubMed ID: 15894332
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroManipulating viral-based therapeutics.
    Tenoever B
    Discov Med; 2009 Aug; 8(41):51-4. PubMed ID: 19788867
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.